Brazilian Position Statement for Familial Chylomicronemia Syndrome – 2023
The report below lists declarations of interest as reported to the SBC by the experts during the period of the development of these statement, 2022.
Expert	Type of relationship with industry
Alceu de Oliveira Toledo Júnior	Nothing to be declared
Ana Cláudia Cavalcante Nogueira	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Servier: Vastarel/Angina. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - PTC: Waylivra/FCS. Any economically relevant equity interest in companies in the healthcare or education industry or in any companies competing with or supplying to SBC: - Teaching and clinical research area.
Ana Cristina Carneiro Fernandes Souto	Nothing to be declared
Ana Maria Pitta Lottenberg	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - PTC Therapeutics: Financial support for lectures.
Ana Paula Marte Chacra	Nothing to be declared
Antonio Carlos Palandri Chagas	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Semaglutida. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Semaglutida. Any other interest (financial or other) that should be declared considering the position taken in SBC that has not been expressly listed above: - Member of the Vita Nova Institute Scientific Committee.
Carlos Eduardo dos Santos Ferreira	Nothing to be declared
Charles Marques Lourenço	Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Sanofi: Biomarin/Achondroplasia; PTC: NiemannPick B/AADC deficiency.
Cynthia Melissa Valerio	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Saxenda, Rybelsus, Ozempic; PTC: Waylivra; Amryt: Myalept. B - Research funding under your direct/personal responsibility (directed to the department or institution) from the Brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amryt: Metreleptina.
Dennys Esper Cintra	Nothing to be declared
Francisco Antonio Helfenstein Fonseca	Nothing to be declared
Gustavo Aguiar Campana	Nothing to be declared
Henrique Tria Bianco	Nothing to be declared
Josivan Gomes de Lima	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Semaglutida. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Semaglutida.
Marcelo Heitor Vieira Assad	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Rybelsus. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Rybelsus.
Maria Cristina de Oliveira Izar	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: Repatha; Amryt Pharma: Lojuxta; AstraZeneca: Dapagliflozina; Aché: Trezor, Trezete; Biolab: Livalo; Abbott: Lipidil; EMS: Rosuvastatina; Eurofarma: Rosuvastatina; Sanofi: Praluent, Zympass, Zympass Eze, Efluelda; Libbs: Plenance, Plenance Eze; Novo Nordisk: Ozempic, Victoza; Servier: Acertamlo, Alertalix; PTCBio: Waylivra. B - Research funding under your direct/personal responsibility (directed to the department or institution) from the Brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - PTCBio: Waylivra; Amgen: Repatha; Novartis: Inclisiran, Pelacarsen; NovoNordisk: Ziltivekimab. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk: Diabetes.
Maria Helane Costa Gurgel Castelo	Nothing to be declared
Marileia Scartezini	Nothing to be declared
Miguel Antonio Moretti	Nothing to be declared
Natasha Slhessarenko Fraife Barreto	Nothing to be declared
Raul Dias dos Santos Filho	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: Evolocumabe; Astra Zenec:Dapagliflozina; Aché:/Rosuvastatina; PTC Therapeutics:Volanesorsen; Novartis: Inclisiran; Novo Nordisk: Semaglutide; Sanofi: Rosuvastatina; Libbs: Rosuvastatina. B - Research funding under your direct/personal responsibility (directed to the department or institution) from the Brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: Evolocumabe; Sanofi: Alirocumabe; Novartis: Inclisiran; Esperion: Ácido Bempedóico; Novartis: Pelacarsen; Kowa: Pemafibrato. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: Cholesterol; Ache: Cholesterol; AstraZeneca: Diabete; Libbs: Cholesterol; Novartis: Cholesterol; Novo Nordisk: Diabetes; Eli-Lilly: Diabetes; Merck: Diabetes; Biolab: Cholesterol.
Rayana Elias Maia	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: PTC: Volanersorsen. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Amgen: PTC: Volanersorsen.
Renan Magalhães Montenegro Junior	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Boheringer, AstraZeneca, Novo Nordisk, PTC, Nestlé, Amryt, Jansen. Outros relacionamentos Financiamento de atividades de educação médica continuada, incluindo viagens, hospedagens e inscrições para congressos e cursos, provenientes da indústria farmacêutica, de órteses, próteses, equipamentos e implantes, brasileiras ou estrangeiras: - Novo Nordisk, Amryt, PTC, Boheringer, Abbott.
Renato Jorge Alves	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Boheringer, AstraZeneca, Novo Nordisk, PTC, Nestlé, Amryt, Jansen. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Novo Nordisk, Amryt, PTC, Boheringer, Abbott.
Roberta Marcondes Machado Figueiredo	Financial declaration A - Economically relevant payments of any kind made to (i) you, (ii) your spouse/partner or any other person living with you, (iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or participant; any payments received for lectures, lessons, training instruction, compensation, fees paid for participation in advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - PTC Therapeutics. Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - PTC Therapeutics.
Rodrigo Ambrosio Fock	Other relationships Funding of continuing medical education activities, including travel, accommodation and registration in conferences and courses, from the brazilian or international pharmaceutical, orthosis, prosthesis, equipment and implants industry: - Biomarin.
Tânia Leme da Rocha Martinez	Nothing to be declared